Journal article · 2016 · Open access

Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013

Ameyo Monique Dorkenoo, Dègninou Yehadji, Yao Mawuenyégan Agbo, Yao Layibo, Foli Agbéko, Poukpessi Adjeloh, Kossi Yakpa, Efoé Sossou, Fantché Awokou, Pascal Ringwald

Malaria Journal, 15(1), 331 · Published 22 June 2016 · DOI 10.1186/s12936-016-1381-8

Open PDFView at the publisherCite this paper

In brief

“Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013” is a 2016 journal article by Ameyo Monique Dorkenoo and 9 co-authors, published in Malaria Journal. OpenAlex counts 47 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Malaria Journal.

Citations
47
Most cited in
2020 (8)
Field-weighted impact
3.22
References
20
Authors
10

Abstract

BACKGROUND: Since 2005, the Togo National Malaria Control Programme has recommended two different formulations of artemisinin-based combination therapy (ACT), artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL), for the treatment of uncomplicated malaria. Regular efficacy monitoring of these two combinations is conducted every 2 or 3 years. This paper reports the latest efficacy assessment results and the investigation of mutations in the k13 propeller domain. METHODS: The study was conducted in 2012-2013 on three sentinel sites of Togo (Lomé, Sokodé and Niamtougou). Children aged 6-59 months, who were symptomatically infected with Plasmodium falciparum, were treated with either AL (Coartem(®), Novartis Pharma, Switzerland) or ASAQ (Co-Arsucam(®), Sanofi Aventis, France). The WHO standard protocol for anti-malarial treatment evaluation was used. The primary end-point was 28-day adequate clinical and parasitological response (ACPR), corrected to exclude reinfection using polymerase-chain reaction (PCR) genotyping. RESULTS: A total of 523 children were included in the study. PCR-corrected ACPR was 96.3-100 % for ASAQ and 97-100 % for AL across the three study sites. Adverse events were negligible: 0-4.8 % across all sites, for both artemisinin-based combinations. Upon investigation of mutations in the k13 propeller domain, only 9 (1.8 %) mutations were reported, three in each site. All mutant parasites were cleared before day 3. All day 3 positive patients were infected with k13 wild type parasites. CONCLUSIONS: The efficacy of AL and ASAQ remains high in Togo, and both drugs are well tolerated. ASAQ and AL would be recommended for the treatment of uncomplicated malaria in Togo.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Dorkenoo, A. M., Yehadji, D., Agbo, Y. M., Layibo, Y., Agbéko, F., Adjeloh, P., Yakpa, K., Sossou, E., Awokou, F., & Ringwald, P. (2016). Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013. Malaria Journal, 15(1), 331. https://doi.org/10.1186/s12936-016-1381-8

MLA 9

Dorkenoo, Ameyo Monique, et al. “Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013.” Malaria Journal, vol. 15, no. 1, 2016, p. 331. https://doi.org/10.1186/s12936-016-1381-8.

Chicago

Dorkenoo, Ameyo Monique, Dègninou Yehadji, Yao Mawuenyégan Agbo, Yao Layibo, Foli Agbéko, Poukpessi Adjeloh, Kossi Yakpa, Efoé Sossou, Fantché Awokou, and Pascal Ringwald. 2016. “Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013.” Malaria Journal 15 (1): 331. https://doi.org/10.1186/s12936-016-1381-8.

Harvard

Dorkenoo, A. M. et al. (2016) ‘Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013’, Malaria Journal, 15(1), p. 331. doi:10.1186/s12936-016-1381-8.

IEEE

A. M. Dorkenoo et al., “Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013,” Malaria Journal, vol. 15, no. 1, p. 331, 2016, doi: 10.1186/s12936-016-1381-8.

BibTeX

@article{dorkenoo2016therapeutic,
  title     = {{Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013}},
  author    = {Dorkenoo, Ameyo Monique and Yehadji, Dègninou and Agbo, Yao Mawuenyégan and Layibo, Yao and Agbéko, Foli and Adjeloh, Poukpessi and Yakpa, Kossi and Sossou, Efoé and Awokou, Fantché and Ringwald, Pascal},
  journal   = {Malaria Journal},
  year      = {2016},
  volume    = {15},
  number    = {1},
  pages     = {331},
  doi       = {10.1186/s12936-016-1381-8},
  url       = {https://doi.org/10.1186/s12936-016-1381-8}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201722
201866
201955
202088
202133
202277
202366
202444
202533
202622

Its field-weighted citation impact is 3.22: it has been cited 3.22 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control

  • artemisinin-based combination therapy
  • uncomplicated malaria
  • Plasmodium falciparum
  • artesunate-amodiaquine
  • artemether-lumefantrine
  • treatment efficacy
  • antimalarial drug resistance
  • children under five

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Dorkenoo, A. M., Yehadji, D., Agbo, Y. M., Layibo, Y., Agbéko, F., Adjeloh, P., Yakpa, K., Sossou, E., Awokou, F., & Ringwald, P. (2016). Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013. Malaria Journal, 15(1), 331. https://doi.org/10.1186/s12936-016-1381-8

How many times has this paper been cited?

47 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Malaria Journal: sign in and open the PDF from this page.

Who wrote this paper?

Ameyo Monique Dorkenoo, Dègninou Yehadji, Yao Mawuenyégan Agbo, Yao Layibo, Foli Agbéko, Poukpessi Adjeloh, Kossi Yakpa, Efoé Sossou, Fantché Awokou, Pascal Ringwald.

What is the DOI of this paper?

10.1186/s12936-016-1381-8, permanently at https://doi.org/10.1186/s12936-016-1381-8. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.